AZN.UK

12,586

+0.74%↑

GSK

1,622

-1.85%↓

HLN.UK

331.8

+0.36%↑

STJ

1,291

+1.1%↑

AZN.UK

12,586

+0.74%↑

GSK

1,622

-1.85%↓

HLN.UK

331.8

+0.36%↑

STJ

1,291

+1.1%↑

AZN.UK

12,586

+0.74%↑

GSK

1,622

-1.85%↓

HLN.UK

331.8

+0.36%↑

STJ

1,291

+1.1%↑

AZN.UK

12,586

+0.74%↑

GSK

1,622

-1.85%↓

HLN.UK

331.8

+0.36%↑

STJ

1,291

+1.1%↑

AZN.UK

12,586

+0.74%↑

GSK

1,622

-1.85%↓

HLN.UK

331.8

+0.36%↑

STJ

1,291

+1.1%↑

Search

Hikma Pharmaceuticals PLC

Abrir

SetorSaúde

1,841 1.43

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1800

Máximo

1856

Indicadores-chave

By Trading Economics

Rendimento

133M

Vendas

100M

1.7B

P/E

Médio do Setor

13.384

35.739

EPS

1.07

Rendimento de Dividendos

5.06

Margem de lucro

8.537

Funcionários

9,500

EBITDA

-29M

259M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+37.72% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.06%

3.08%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.4B

3.7B

Abertura anterior

1839.57

Fecho anterior

1841

Sentimento de Notícias

By Acuity

41%

59%

120 / 371 Ranking em Healthcare

Hikma Pharmaceuticals PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

1 de out. de 2025, 08:54 UTC

Grandes Movimentos do Mercado

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

8 de abr. de 2025, 08:20 UTC

Conversa de Mercado

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Comparação entre Pares

Variação de preço

Hikma Pharmaceuticals PLC Previsão

Preço-alvo

By TipRanks

37.72% parte superior

Previsão para 12 meses

Média 2,472 GBX  37.72%

Máximo 2,850 GBX

Mínimo 1,982 GBX

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Hikma Pharmaceuticals PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

5

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

120 / 371 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat